Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy

Jennifer Phan, Priyadarsini Kumar, Dake Hao, Kewa Gao, Diana L Farmer, Aijun Wang

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Through traditional medicine, there were diseases and disorders that previously remained untreated or were simply thought to be incurable. Since the discovery of mesenchymal stem cells (MSCs), there has been a flurry of research to develop MSC-based therapy for diseases and disorders. It is now well-known that MSCs do not typically engraft after transplantation and exhibit their therapeutic effect via a paracrine mechanism. In addition to secretory proteins, MSCs also produce extracellular vesicles (EVs), membrane-bound nanovesicles containing proteins, DNA and RNA. The secreted vesicles then interact with target cells and deliver their contents, imparting their ultimate therapeutic effect. Unlike the widely studied cancer cells, the yield of MSC-exosomes is a limiting factor for large-scale production for cell-free therapies. Here we summarise potential approaches to increase the yield of such vesicles while maintaining or enhancing their efficacy by engineering the extracellular environment and intracellular components of MSCs.

Original languageEnglish (US)
Article number1522236
JournalJournal of Extracellular Vesicles
Volume7
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Exosomes
Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
Therapeutic Uses
Traditional Medicine
Proteins
Transplantation
RNA
Membranes
DNA
Research
Neoplasms

Keywords

  • extracellular vesicles
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Histology
  • Cell Biology

Cite this

Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy. / Phan, Jennifer; Kumar, Priyadarsini; Hao, Dake; Gao, Kewa; Farmer, Diana L; Wang, Aijun.

In: Journal of Extracellular Vesicles, Vol. 7, No. 1, 1522236, 01.01.2018.

Research output: Contribution to journalReview article

@article{ef4b637898d84c2ba2dcb1da7c4b8b73,
title = "Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy",
abstract = "Through traditional medicine, there were diseases and disorders that previously remained untreated or were simply thought to be incurable. Since the discovery of mesenchymal stem cells (MSCs), there has been a flurry of research to develop MSC-based therapy for diseases and disorders. It is now well-known that MSCs do not typically engraft after transplantation and exhibit their therapeutic effect via a paracrine mechanism. In addition to secretory proteins, MSCs also produce extracellular vesicles (EVs), membrane-bound nanovesicles containing proteins, DNA and RNA. The secreted vesicles then interact with target cells and deliver their contents, imparting their ultimate therapeutic effect. Unlike the widely studied cancer cells, the yield of MSC-exosomes is a limiting factor for large-scale production for cell-free therapies. Here we summarise potential approaches to increase the yield of such vesicles while maintaining or enhancing their efficacy by engineering the extracellular environment and intracellular components of MSCs.",
keywords = "extracellular vesicles, Mesenchymal stem cells",
author = "Jennifer Phan and Priyadarsini Kumar and Dake Hao and Kewa Gao and Farmer, {Diana L} and Aijun Wang",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/20013078.2018.1522236",
language = "English (US)",
volume = "7",
journal = "Journal of Extracellular Vesicles",
issn = "2001-3078",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy

AU - Phan, Jennifer

AU - Kumar, Priyadarsini

AU - Hao, Dake

AU - Gao, Kewa

AU - Farmer, Diana L

AU - Wang, Aijun

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Through traditional medicine, there were diseases and disorders that previously remained untreated or were simply thought to be incurable. Since the discovery of mesenchymal stem cells (MSCs), there has been a flurry of research to develop MSC-based therapy for diseases and disorders. It is now well-known that MSCs do not typically engraft after transplantation and exhibit their therapeutic effect via a paracrine mechanism. In addition to secretory proteins, MSCs also produce extracellular vesicles (EVs), membrane-bound nanovesicles containing proteins, DNA and RNA. The secreted vesicles then interact with target cells and deliver their contents, imparting their ultimate therapeutic effect. Unlike the widely studied cancer cells, the yield of MSC-exosomes is a limiting factor for large-scale production for cell-free therapies. Here we summarise potential approaches to increase the yield of such vesicles while maintaining or enhancing their efficacy by engineering the extracellular environment and intracellular components of MSCs.

AB - Through traditional medicine, there were diseases and disorders that previously remained untreated or were simply thought to be incurable. Since the discovery of mesenchymal stem cells (MSCs), there has been a flurry of research to develop MSC-based therapy for diseases and disorders. It is now well-known that MSCs do not typically engraft after transplantation and exhibit their therapeutic effect via a paracrine mechanism. In addition to secretory proteins, MSCs also produce extracellular vesicles (EVs), membrane-bound nanovesicles containing proteins, DNA and RNA. The secreted vesicles then interact with target cells and deliver their contents, imparting their ultimate therapeutic effect. Unlike the widely studied cancer cells, the yield of MSC-exosomes is a limiting factor for large-scale production for cell-free therapies. Here we summarise potential approaches to increase the yield of such vesicles while maintaining or enhancing their efficacy by engineering the extracellular environment and intracellular components of MSCs.

KW - extracellular vesicles

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=85054197836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054197836&partnerID=8YFLogxK

U2 - 10.1080/20013078.2018.1522236

DO - 10.1080/20013078.2018.1522236

M3 - Review article

AN - SCOPUS:85054197836

VL - 7

JO - Journal of Extracellular Vesicles

JF - Journal of Extracellular Vesicles

SN - 2001-3078

IS - 1

M1 - 1522236

ER -